ClinicalTrials.Veeva

Menu

Moviprep® Versus Fleet Phospho-Soda® (Golden Standard): A Study That Compared Two Laxatives on Patients Undergoing Colo-Rectal Cleansing Prior to an Abdominal Operation

G

Ghent University Hospital (UZ)

Status and phase

Completed
Phase 4

Conditions

Colorectal Cleansing Prior Operation

Treatments

Drug: Moviprep®
Drug: Fleet

Study type

Interventional

Funder types

Other

Identifiers

NCT00618930
2007/320

Details and patient eligibility

About

The patients are assigned by randomisation on one of the two laxatives. After cleansing they have to fill in an evaluation form to report their findings and difficulties. Also the surgeon will be asked to fill in a score-form to report all details concerning the bowel preparation.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women
  • Older than 18
  • Informed consent signed
  • Mode of surgery

Exclusion criteria

  • Renal disease
  • Heart failure
  • Dehydration
  • Abdominal obstruction
  • Abdominal perforation
  • Abdominal paralysis
  • Toxic megacolon

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

1
Experimental group
Treatment:
Drug: Moviprep®
2
Active Comparator group
Description:
Use of Fleet
Treatment:
Drug: Fleet

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems